Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study

BACKGROUND: Whether lower dose cabergoline therapy for hyperprolactinemia increases risk of valvular dysfunction remains controversial. We examined valvular abnormalities among asymptomatic adults with hyperprolactinemia treated with dopamine agonists. METHODS: This cross-sectional study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Budayr, Amer, Tan, Thida C., Lo, Joan C., Zaroff, Jonathan G., Tabada, Grace H., Yang, Jingrong, Go, Alan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031983/
https://www.ncbi.nlm.nih.gov/pubmed/32075620
http://dx.doi.org/10.1186/s12902-020-0507-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031983/
https://www.ncbi.nlm.nih.gov/pubmed/32075620
http://dx.doi.org/10.1186/s12902-020-0507-8

Ejemplares similares